The United States Food and Drug Administration (FDA) has approved suzetrigine, a non-opioid painkiller, for short-term pain management. This approval marks the first time in over two decades that a new pain relief mechanism has been introduced. Suzetrigine, which selectively targets sodium channels on pain-sensing neurons, has been developed as an alternative to opioids, which have been linked to addiction …
Read More »U.S. Approves Vertex’s Non-Opioid Painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals’ (VRTX) non-opioid painkiller pill that has a low risk of addiction. Vertex is the first drugmaker in decades to gain U.S. approval for a new type of pain medicine. Past and current painkillers come with dependency risks, notably cheap and widely available opioids that have caused an epidemic …
Read More »